Plasma Therapy Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032
CHAPTER 1. Industry Overview of Plasma Therapy Market
1.1. Definition and Scope
1.1.1. Definition of Plasma Therapy
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Plasma Therapy Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Plasma Therapy Market By Type
1.2.3. Plasma Therapy Market By Source
1.2.4. Plasma Therapy Market By Application
1.2.5. Plasma Therapy Market By End User
1.2.6. Plasma Therapy Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Plasma Therapy Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Plasma Therapy Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Plasma Therapy Market By Type
5.1. Introduction
5.2. Plasma Therapy Revenue By Type
5.2.1. Plasma Therapy Revenue (USD Million) and Forecast, By Type, 2020-2032
5.2.2. Leukocyte-Rich Fibrin
5.2.2.1. Leukocyte-Rich Fibrin Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Pure Platelet-Rich Fibrin
5.2.3.1. Pure Platelet-Rich Fibrin Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Leukocyte-Rich PRP
5.2.4.1. Leukocyte-Rich PRP Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Pure PRP
5.2.5.1. Pure PRP Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Plasma Therapy Market By Source
6.1. Introduction
6.2. Plasma Therapy Revenue By Source
6.2.1. Plasma Therapy Revenue (USD Million) and Forecast, By Source, 2020-2032
6.2.2. Allogenic
6.2.2.1. Allogenic Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Autologous
6.2.3.1. Autologous Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Plasma Therapy Market By Application
7.1. Introduction
7.2. Plasma Therapy Revenue By Application
7.2.1. Plasma Therapy Revenue (USD Million) and Forecast, By Application, 2020-2032
7.2.2. Cardiac Muscle Injury
7.2.2.1. Cardiac Muscle Injury Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Dental
7.2.3.1. Dental Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Nerve Injury
7.2.4.1. Nerve Injury Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.5. Dermatology
7.2.5.1. Dermatology Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.6. Orthopedic
7.2.6.1. Orthopedic Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.7. Others
7.2.7.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. Plasma Therapy Market By End User
8.1. Introduction
8.2. Plasma Therapy Revenue By End User
8.2.1. Plasma Therapy Revenue (USD Million) and Forecast, By End User, 2020-2032
8.2.2. Hospitals and Clinics
8.2.2.1. Hospitals and Clinics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.3. Research Institutes
8.2.3.1. Research Institutes Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.4. Others
8.2.4.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Plasma Therapy Market By Country
9.1. North America Plasma Therapy Market Overview
9.2. U.S.
9.2.1. U.S. Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
9.2.2. U.S. Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
9.2.3. U.S. Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
9.2.4. U.S. Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
9.3. Canada
9.3.1. Canada Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
9.3.2. Canada Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
9.3.3. Canada Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
9.3.4. Canada Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Plasma Therapy Market By Country
10.1. Europe Plasma Therapy Market Overview
10.2. U.K.
10.2.1. U.K. Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
10.2.2. U.K. Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
10.2.3. U.K. Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
10.2.4. U.K. Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
10.3. Germany
10.3.1. Germany Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
10.3.2. Germany Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
10.3.3. Germany Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
10.3.4. Germany Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
10.4. France
10.4.1. France Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
10.4.2. France Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
10.4.3. France Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
10.4.4. France Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
10.5. Spain
10.5.1. Spain Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
10.5.2. Spain Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
10.5.3. Spain Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
10.5.4. Spain Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
10.6.2. Rest of Europe Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
10.6.3. Rest of Europe Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
10.6.4. Rest of Europe Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Plasma Therapy Market By Country
11.1. Asia Pacific Plasma Therapy Market Overview
11.2. China
11.2.1. China Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
11.2.2. China Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
11.2.3. China Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
11.2.4. China Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
11.3. Japan
11.3.1. Japan Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
11.3.2. Japan Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
11.3.3. Japan Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
11.3.4. Japan Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
11.4. India
11.4.1. India Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
11.4.2. India Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
11.4.3. India Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
11.4.4. India Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
11.5. Australia
11.5.1. Australia Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
11.5.2. Australia Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
11.5.3. Australia Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
11.5.4. Australia Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
11.6. South Korea
11.6.1. South Korea Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
11.6.2. South Korea Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
11.6.3. South Korea Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
11.6.4. South Korea Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
11.7.2. Rest of Asia-Pacific Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
11.7.3. Rest of Asia-Pacific Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
11.7.4. Rest of Asia-Pacific Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Plasma Therapy Market By Country
12.1. Latin America Plasma Therapy Market Overview
12.2. Brazil
12.2.1. Brazil Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
12.2.2. Brazil Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
12.2.3. Brazil Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
12.2.4. Brazil Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
12.3. Mexico
12.3.1. Mexico Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
12.3.2. Mexico Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
12.3.3. Mexico Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
12.3.4. Mexico Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
12.4.2. Rest of Latin America Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
12.4.3. Rest of Latin America Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
12.4.4. Rest of Latin America Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Plasma Therapy Market By Country
13.1. Middle East & Africa Plasma Therapy Market Overview
13.2. GCC
13.2.1. GCC Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
13.2.2. GCC Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
13.2.3. GCC Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
13.2.4. GCC Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
13.3. South Africa
13.3.1. South Africa Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
13.3.2. South Africa Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
13.3.3. South Africa Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
13.3.4. South Africa Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Plasma Therapy Revenue (USD Million) and Forecast By Source, 2020-2032
13.4.2. Rest of Middle East & Africa Plasma Therapy Revenue (USD Million) and Forecast By Type, 2020-2032
13.4.3. Rest of Middle East & Africa Plasma Therapy Revenue (USD Million) and Forecast By Application, 2020-2032
13.4.4. Rest of Middle East & Africa Plasma Therapy Revenue (USD Million) and Forecast By End User, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Plasma Therapy Market
14.1. Plasma Therapy Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Plasma Therapy Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Arthrex
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Million), 2022
15.1.3.2. Arthrex 2022 Plasma Therapy Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Zimmer Biomet
15.3. DePuy Synthes
15.4. EmCyte
15.5. Regen Lab
15.6. ISTO Biologics
15.7. Cesca Therapeutics
15.8. Weigao
15.9. REV-MED
15.10. Nuo Therapeutics
15.11. Terumo
Frequently Asked Questions
How big is the plasma therapy market?
The plasma therapy market size was valued at USD 342.8 million in 2022.
What is the CAGR of the global plasma therapy market from 2024 to 2032?
The CAGR of plasma therapy is 12.8% during the analysis period of 2024 to 2032.
Which are the key players in the plasma therapy market?
The key players operating in the global market are including Arthrex, Zimmer Biomet, DePuy Synthes, EmCyte, Regen Lab, ISTO Biologics, Cesca Therapeutics, Weigao, REV-MED, Nuo Therapeutics, and Terumo.
Which region dominated the global plasma therapy market share?
North America held the dominating position in plasma therapy industry during the analysis period of 2024 to 2032.
Which region registered fastest CAGR from 2024 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of plasma therapy during the analysis period of 2024 to 2032.
What are the current trends and dynamics in the global plasma therapy industry?
The current trends and dynamics in the plasma therapy industry include growing demand for regenerative medicine solutions, increasing prevalence of chronic diseases, advancements in plasma processing technologies, and rising adoption of minimally invasive procedures.
Which type held the maximum share in 2022?
The pure PRP type held the maximum share of the plasma therapy industry.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
